E Europe Ltd 13D and 13G filings for NeuroSense Therapeutics Ltd.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-03-15 3:32 pm Sale |
2022-01-11 | 13G | NeuroSense Therapeutics Ltd. NRSN |
E Europe Ltd | 0 0.000% |
-602,502 (Position Closed) |
Filing |
| 2021-12-30 11:13 am Purchase |
2021-12-13 | 13G | NeuroSense Therapeutics Ltd. NRSN |
E Europe Ltd | 602,502 5.510% |
602,502 (New Position) |
Filing |